Stock Track | Inspire Medical Systems Plunges 18.60% in Pre-Market on Weak Q1 Results and Drastic 2026 Guidance Cut

Stock Track05-05

Inspire Medical Systems' stock experienced a sharp pre-market plunge of 18.60% on Tuesday, extending losses from the previous trading session.

The sell-off was triggered by the company's first-quarter 2026 financial results, which revealed a GAAP diluted loss per share of $0.39 and a net loss of $11.3 million, despite revenue of $204.6 million slightly beating analyst estimates. The primary catalyst for the negative investor sentiment was a significant reduction in the company's full-year 2026 outlook.

Inspire Medical Systems drastically lowered its annual revenue guidance to a range of $825 million to $875 million, representing a potential decline of 4% to 10% compared to 2025 and falling well below the FactSet consensus estimate of $961.9 million. The company also slashed its adjusted EPS forecast to $0.75-$1.25 from a prior range of $1.85-$2.35, compared to the $1.96 analyst expectation. Management attributed the weakened outlook to ongoing disruption from coding and reimbursement uncertainty, along with the impact of its WISeR program, challenges it expects to persist throughout the year.

In response to the disappointing results and guidance, several Wall Street analysts promptly cut their price targets on the stock, including JP Morgan (to $54 from $67), RBC Capital Markets (to $45 from $56), Truist Securities (to $50 from $64), and Leerink Partners (to $52 from $78), further pressuring the stock price in pre-market trading.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1102002565?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-05 16:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1102002565","market":"nz","top_or_hot":-1,"title":"Stock Track | Inspire Medical Systems Plunges 18.60% in Pre-Market on Weak Q1 Results and Drastic 2026 Guidance Cut","media":"Stock Track","content":"<p>Inspire Medical Systems' stock experienced a sharp pre-market plunge of 18.60% on Tuesday, extending losses from the previous trading session.</p><p>The sell-off was triggered by the company's first-quarter 2026 financial results, which revealed a GAAP diluted loss per share of $0.39 and a net loss of $11.3 million, despite revenue of $204.6 million slightly beating analyst estimates. The primary catalyst for the negative investor sentiment was a significant reduction in the company's full-year 2026 outlook.</p><p>Inspire Medical Systems drastically lowered its annual revenue guidance to a range of $825 million to $875 million, representing a potential decline of 4% to 10% compared to 2025 and falling well below the FactSet consensus estimate of $961.9 million. The company also slashed its adjusted EPS forecast to $0.75-$1.25 from a prior range of $1.85-$2.35, compared to the $1.96 analyst expectation. Management attributed the weakened outlook to ongoing disruption from coding and reimbursement uncertainty, along with the impact of its WISeR program, challenges it expects to persist throughout the year.</p><p>In response to the disappointing results and guidance, several Wall Street analysts promptly cut their price targets on the stock, including JP Morgan (to $54 from $67), RBC Capital Markets (to $45 from $56), Truist Securities (to $50 from $64), and Leerink Partners (to $52 from $78), further pressuring the stock price in pre-market trading.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Inspire Medical Systems Plunges 18.60% in Pre-Market on Weak Q1 Results and Drastic 2026 Guidance Cut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Inspire Medical Systems Plunges 18.60% in Pre-Market on Weak Q1 Results and Drastic 2026 Guidance Cut\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-05 16:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Inspire Medical Systems' stock experienced a sharp pre-market plunge of 18.60% on Tuesday, extending losses from the previous trading session.</p><p>The sell-off was triggered by the company's first-quarter 2026 financial results, which revealed a GAAP diluted loss per share of $0.39 and a net loss of $11.3 million, despite revenue of $204.6 million slightly beating analyst estimates. The primary catalyst for the negative investor sentiment was a significant reduction in the company's full-year 2026 outlook.</p><p>Inspire Medical Systems drastically lowered its annual revenue guidance to a range of $825 million to $875 million, representing a potential decline of 4% to 10% compared to 2025 and falling well below the FactSet consensus estimate of $961.9 million. The company also slashed its adjusted EPS forecast to $0.75-$1.25 from a prior range of $1.85-$2.35, compared to the $1.96 analyst expectation. Management attributed the weakened outlook to ongoing disruption from coding and reimbursement uncertainty, along with the impact of its WISeR program, challenges it expects to persist throughout the year.</p><p>In response to the disappointing results and guidance, several Wall Street analysts promptly cut their price targets on the stock, including JP Morgan (to $54 from $67), RBC Capital Markets (to $45 from $56), Truist Securities (to $50 from $64), and Leerink Partners (to $52 from $78), further pressuring the stock price in pre-market trading.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INSP","symbol_name":"Inspire Medical Systems","start_time":0,"source_url":"","article_id":"1102002565","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1102002565","pubTimestamp":1777968424,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Inspire Medical Systems' stock experienced a sharp pre-market plunge of 18.60% on Tuesday, extending losses from the previous trading session.The sell-off was triggered by the company's first-quarter...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"INSP":"Inspire Medical Systems"},"translate_title":"个股追踪|Inspire Medical Systems盘前暴跌18.60%，因Q1业绩疲弱且大幅下调2026年指引","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INSP":1},"content_text":"Inspire Medical Systems' stock experienced a sharp pre-market plunge of 18.60% on Tuesday, extending losses from the previous trading session.The sell-off was triggered by the company's first-quarter 2026 financial results, which revealed a GAAP diluted loss per share of $0.39 and a net loss of $11.3 million, despite revenue of $204.6 million slightly beating analyst estimates. The primary catalyst for the negative investor sentiment was a significant reduction in the company's full-year 2026 outlook.Inspire Medical Systems drastically lowered its annual revenue guidance to a range of $825 million to $875 million, representing a potential decline of 4% to 10% compared to 2025 and falling well below the FactSet consensus estimate of $961.9 million. The company also slashed its adjusted EPS forecast to $0.75-$1.25 from a prior range of $1.85-$2.35, compared to the $1.96 analyst expectation. Management attributed the weakened outlook to ongoing disruption from coding and reimbursement uncertainty, along with the impact of its WISeR program, challenges it expects to persist throughout the year.In response to the disappointing results and guidance, several Wall Street analysts promptly cut their price targets on the stock, including JP Morgan (to $54 from $67), RBC Capital Markets (to $45 from $56), Truist Securities (to $50 from $64), and Leerink Partners (to $52 from $78), further pressuring the stock price in pre-market trading.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1102002565","isCrawlerRequest":true}